SkinHealth Systems (SKIN) Common Equity (2020 - 2026)

SkinHealth Systems (SKIN) has reported Common Equity for 7 consecutive years, with $55.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 24.91% year-over-year to $55.6 million in Q2 2026; TTM through Jun 2026 was $55.6 million, a 24.91% decrease from a year earlier, with the FY2025 full-year figure at $61.1 million, up 17.86% from the prior year.
• Common Equity was $55.6 million for Q2 2026 at SkinHealth Systems, up from $55.2 million in the prior quarter.
• Over five years, Common Equity peaked at $345.4 million in Q2 2022 and troughed at $46.1 million in Q1 2025.
• A 5-year average of $120.3 million and a median of $67.4 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity surged 2049.38% in 2022 and plunged 64.45% in 2023, its largest moves.
• Over 5 years, Common Equity stood at $167.1 million in 2022, then sank by 64.45% to $59.4 million in 2023, then dropped by 12.77% to $51.8 million in 2024, then advanced by 17.86% to $61.1 million in 2025, then retreated by 8.99% to $55.6 million in 2026.
• The last three Common Equity figures came in at $55.6 million (Q2 2026), $55.2 million (Q1 2026), and $61.1 million (Q4 2025), per Business Quant data.